We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: precision medicine
MedXY News
EnglishTag

precision medicine

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine Imperative
Cardiologyprecision medicineThiết kế Thử nghiệm Lâm sàng

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine Imperative

By MedXY|Sep 15, 2026

Clonal hematopoiesis of indeterminate potential (CHIP) poses a novel cardiovascular risk. This article explores challenges and strategies for designing cardiovascular outcomes trials tailored to CHIP’s genetic heterogeneity and clinical com

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions
Cardiologyprecision medicine
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
molecular subphenotypes

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions

By MedXY|Sep 13, 2026

Rapid immunoassay-based classifiers accurately identify hyper- and hypoinflammatory subphenotypes in critically ill children, preserving prognostic and predictive utility and enabling precision therapies in acute pediatric cardiorespiratory

Coordinated Precision Care for Rare Genetic Obesity: European Expert Consensus on Centers of Expertise and Structured Monitoring
Diabetes & Endocrinologyprecision medicinegenetic obesity

Coordinated Precision Care for Rare Genetic Obesity: European Expert Consensus on Centers of Expertise and Structured Monitoring

By MedXY|Aug 25, 2026

European experts recommend designated centers, structured diagnostic pathways, and real‑world monitoring to deliver precision therapies (MC4R agonists) safely and equitably to people with rare genetic forms of obesity.

Inflammatory Phenotypes in Severe Pneumonia: Bridging Clinical Insights and Mouse Models for Targeted Therapies
Critical Careprecision medicinecritical care

Inflammatory Phenotypes in Severe Pneumonia: Bridging Clinical Insights and Mouse Models for Targeted Therapies

By MedXY|Aug 23, 2026

This article explores hyperinflammatory and hypoinflammatory phenotypes in severe pneumonia, their clinical impact, and translational mouse models that inform precision therapeutic strategies.

Precision Medicine Enhances Management but Not Complications in Young-Onset Diabetes: Insights from the PRISM Randomized Trial
Diabetes & EndocrinologyCardiometabolic controlMonogenic Diabetes

Precision Medicine Enhances Management but Not Complications in Young-Onset Diabetes: Insights from the PRISM Randomized Trial

By MedXY|Jul 8, 2026

The PRISM trial evaluated a precision medicine program using biogenetic markers and multidisciplinary care in Chinese young-onset diabetes patients, improving metabolic control and patient well-being but not reducing complications over thre

Impact of Acetaldehyde Metabolism on Alcohol-Related Inflammatory Bowel Disease Risk: A Precision Medicine Perspective
GastroenterologyAcetaldehyde MetabolismAlcohol Consumption

Impact of Acetaldehyde Metabolism on Alcohol-Related Inflammatory Bowel Disease Risk: A Precision Medicine Perspective

By MedXY|Jul 3, 2026

This study elucidates how genetic differences in acetaldehyde metabolism modify the risk of alcohol-associated inflammatory bowel disease (IBD), highlighting personalized prevention strategies.

Precision Prescribing of SGLT2 Inhibitors in People With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study
Cardiologycardiovascular riskheart failure prevention

Precision Prescribing of SGLT2 Inhibitors in People With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study

By MedXY|Jun 10, 2026

The SABRE model estimates which people with type 2 diabetes may benefit most from SGLT2 inhibitors to prevent heart failure before it develops.

Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure
Cardiologyheart failure preventionprecision medicine

Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure

By MedXY|Jun 3, 2026

A validated model, SABRE, estimates who with type 2 diabetes may gain the most heart-failure prevention benefit from SGLT2 inhibitors, enabling more precise, individualized prescribing.

Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification
Clinical Updatescopy number variantsGenetic Psychiatry

Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification

By MedXY|May 31, 2026

This review synthesizes evidence on how recurrent copy number variants (rCNVs) and polygenic scores (PGSs) jointly influence psychiatric risk, highlighting their complementary roles in clinical risk assessment and the emergence of precision

Cardiovascular Benefit of CPAP May Be Greater in High-Risk Obstructive Sleep Apnoea
Cardiologycardiovascular outcomesCPAP

Cardiovascular Benefit of CPAP May Be Greater in High-Risk Obstructive Sleep Apnoea

By MedXY|May 15, 2026

This pooled analysis found that CPAP may lower cardiovascular event risk mainly in patients with high-risk obstructive sleep apnoea, especially those with stronger heart-rate surges or greater oxygen deprivation during sleep.

Precision Blood-Based Diagnostics for Alzheimer’s Disease: The Synergistic Role of Plasma p-tau217 and eMTBR-tau243
Clinical UpdatesAlzheimer's diseasebiomarkers

Precision Blood-Based Diagnostics for Alzheimer’s Disease: The Synergistic Role of Plasma p-tau217 and eMTBR-tau243

By MedXY|Apr 9, 2026

This review synthesizes recent clinical evidence on the integration of plasma p-tau217 and eMTBR-tau243, highlighting how sequential biomarker testing improves the diagnosis of symptomatic Alzheimer’s disease and predicts longitudinal cogni

Precision Phenotyping in Cardiometabolic Medicine: Genetic Susceptibility of Diabetes Subtypes and Coronary Artery Disease Risk
Cardiologycoronary artery diseaseMendelian Randomization

Precision Phenotyping in Cardiometabolic Medicine: Genetic Susceptibility of Diabetes Subtypes and Coronary Artery Disease Risk

By MedXY|Apr 2, 2026

This review synthesizes evidence on the genetic architecture of adult-onset diabetes subtypes, highlighting that Moderate Obesity-related Diabetes (MOD) is uniquely and causally linked to coronary artery disease risk through polygenic and M

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus
Diabetes & EndocrinologyGestational Diabetesmachine learning

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus

By MedXY|Mar 22, 2026

A groundbreaking machine learning study of over 37,000 patients identifies four distinct GDM phenotypic clusters. These findings demonstrate that early-diagnosed, high-comorbidity phenotypes carry a four-fold increased risk of postpartum di

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome
CardiologyFBN1 MutationMarfan Syndrome

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome

By MedXY|Mar 11, 2026

A breakthrough study reveals that specific FBN1 genotypes, particularly in-frame variants in the DNCD region, significantly elevate the risk of early mitral valve surgery in Marfan syndrome patients, paving the way for genotype-guided clini

Global Diversity in Autoimmune Gastritis: Deciphering Regional Phenotypes and Neoplastic Risks
GastroenterologyGastric Cancerneuroendocrine tumors

Global Diversity in Autoimmune Gastritis: Deciphering Regional Phenotypes and Neoplastic Risks

By MedXY|Mar 9, 2026

An international multicentre study of 1,240 patients reveals that autoimmune gastritis presentation varies by region, with distinct risk factors—including age, intestinal metaplasia, and extreme hypergastrinemia—driving the development of g

Mapping Multimorbidity in Severe Asthma: Defining Replicable Phenotypes to Optimize Personalized Care
Allergy & Immunologymultimorbidityprecision medicine

Mapping Multimorbidity in Severe Asthma: Defining Replicable Phenotypes to Optimize Personalized Care

By MedXY|Mar 3, 2026

This review analyzes findings from the pan-European SHARP registry study, identifying distinct multimorbidity phenotypes in severe asthma. It highlights the impact of steroid-associated and sinonasal clusters on clinical outcomes, advocatin

Synergistic Benefits of Plant-Based Lifestyles and Genetic Resilience: A New Paradigm for Coronary Heart Disease Prevention
CardiologyCoronary heart diseaseplant-based diet

Synergistic Benefits of Plant-Based Lifestyles and Genetic Resilience: A New Paradigm for Coronary Heart Disease Prevention

By MedXY|Mar 5, 2026

This review synthesizes findings on the hPDI-Lifestyle score, demonstrating that adherence to a healthy plant-based diet combined with ideal behaviors significantly mitigates coronary heart disease risk, particularly among those with high g

Moving Beyond Birthdays: Five-Year Absolute Risk-Based Screening Outperforms Age-Based Mammography
newsbreast cancer screeningmammography

Moving Beyond Birthdays: Five-Year Absolute Risk-Based Screening Outperforms Age-Based Mammography

By MedXY|Feb 9, 2026

A CISNET modeling study demonstrates that mammography screening tailored to 5-year absolute invasive breast cancer risk reduces false-positive recalls by up to 23% while maintaining or improving mortality benefits compared to traditional ag

Genetic Blueprints of Skin Fragility: Predicting RDEB Severity Through COL7A1 Variant Mapping
Dermatologygeneticsprecision medicine

Genetic Blueprints of Skin Fragility: Predicting RDEB Severity Through COL7A1 Variant Mapping

By MedXY|Feb 5, 2026

A systematic review of 1,802 patients reveals that COL7A1 variant type and location, particularly premature termination codons and NC1 domain involvement, are definitive predictors of clinical severity and systemic complications in recessiv

Predicting the Clock: Machine Learning Refines Insulin Timing in Gestational Diabetes Management
Diabetes & EndocrinologyGestational Diabetesmachine learning

Predicting the Clock: Machine Learning Refines Insulin Timing in Gestational Diabetes Management

By MedXY|Feb 4, 2026

A secondary analysis of the EMERGE trial reveals that Random Survival Forest models utilizing early glycemic data can accurately predict the time to insulin initiation in women with gestational diabetes, offering a roadmap for personalized

1 / 3
123
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities